Clinical Trials Browser

Phase 1 × Interventional × Hyperbilirubinemia × Clear all

NCT03259581 2022-03-21

Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Hyperbilirubinemia